Download PDF
Klin Monbl Augenheilkd 2003; 220(9): 579-617
DOI: 10.1055/s-2003-42809
Übersicht
© Georg Thieme Verlag Stuttgart · New York

Arteriitis cranialis - Ein Überblick

(Arteriitis temporalis Horton, Riesenzellarteriitis)Cranial arteritis - An Overview(Temporal Arteritis, Giant Cell Arteritis, also known as Horton's Arteritis)Dieter  Schmidt1
  • 1Universitäts-Augenklinik, Freiburg
Further Information

Publication History

Eingegangen: 21. Juli 2003

Angenommen: 25. August 2003

Publication Date:
08 October 2003 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Hintergrund: Das Krankheitsbild der Arteriitis cranialis stellt eine der wichtigsten ophthalmologischen Notfallsituationen dar. Methodik: Literaturübersicht unterschiedlicher diagnostischer Möglichkeiten und therapeutischer Empfehlungen. Ergebnisse: Die grundlegenden diagnostischen Schritte, insbesondere die „5-Kriterien-Klassifikation” (einschließlich bestimmter Ausnahmen) sowie die Erkennung unterschiedlicher Facetten des Krankheitsbildes, werden herausgestellt. Sonderformen der Krankheit, vor allem die Entzündung der A. facialis, A. occipitalis und der A. vertebralis, werden unterschieden. Eine Arteriitis ohne Kopfschmerzen (okkulte Arteriitis) wird meistens zu spät erkannt. Bei fehlenden klassischen Symptomen besteht die große Gefahr einer Fehldiagnose. Die anteriore ischämische Optikusneuropathie (AION) stellt die häufigste Erblindungsursache dar. In der Differenzialdiagnose zur nichtarteriitischen AION werden die charakteristischen Befunde der arteriitischen AION herausgestellt. Die unterschiedlichen Auffassungen zur ein- oder beidseitigen Arterienresektion („Biopsie”) sowie die Befunde der Farb-Duplex-Sonographie der Schläfenarterie im Vergleich zum histologischen Ergebnis werden hervorgehoben. Zusätzliche neuere diagnostische Verfahren wie die MRI-Untersuchung mit Gadolinium und PET-Scan-Untersuchungen können diagnostisch hilfreich sein. Schlussfolgerungen: Erkrankungen an Arteriitis cranialis wurden in den letzten Jahren häufiger diagnostiziert. Die Diagnose sollte von Augenärzten gemeinsam mit Internisten und Neurologen gestellt werden. Erblindungen traten dann auf, wenn die Krankheit zu spät erkannt wurde. Die jahrzehntelange klinische Erfahrung hat dazu geführt, eine hochdosierte systemische Therapie stets frühzeitig zu veranlassen, um Blindheit zu verhindern.

Abstract

Background: Cranial arteritis is one of the most important emergency situations in ophthalmology. Method: Recommendations of the literature how to diagnose and how to treat the disease are described. Results: The basic diagnostic steps such as the „Five Criteria Classification” together with certain exceptions of the classification criteria and the recognition of different facets of the varying clinical picture are emphasised. Special arteritic appearances of the facial artery, the occipital artery and the vertebral artery should be noted and identified. It is pointed out that an arteritis without headache is of great clinical importance, known as occult arteritis, because of the lack of classical symptoms, often leading to a wrong diagnosis. Anterior ischaemic optic neuropathy (AION) is the most frequent cause of blindness. Differential diagnosis between non-arteritic and arteritic AION is emphasised. The different arguments concerning the performance of unilateral or bilateral arterial resection („biopsy”) and the findings of colour duplex ultrasonography in comparison to the histological results are discussed. It is also pointed out that some new diagnostic procedures such as the MRI examination with gadolinium and the PET-Scan examination may be helpful in supporting the diagnosis. Conclusions: Cranial arteritis is more often diagnosed in recent years. The diagnosis should be made in cooperation by the ophthalmologist and internists and neurologists. Blindness caused by cranial arteritis is preventable in the majority of patients if diagnosed early and treated properly. For decades of clinical experience it has been well established that early diagnosis and systemic treatment with high doses of systemic corticosteroids are essential in preventing blindness in one or both eyes.

Schlüsselwörter

Riesenzellarteriitis - anteriore ischämische Optikusneuropathie - Zentralarterienverschluss - Duplex-Sonographie - Kopfschmerzen - histologischer Arterienbefund

Key words

Giant cell arteritis - anterior ischaemic optic neuropathy - central retinal artery occlusion - Duplex sonography - headache - histological arterial findings

Literatur

  • 1 Achkar A A, Lie J T, Gabriel S E, Hunder G G. Giant cell arteritis involving the facial artery.  J Rheumatol. 1995;  22 360-362
    PubMedGoogle Scholar
  • 2 Albert D M, Ruchman M C, Keltner J L. Skip areas in temporal arteritis.  Arch Ophthalmol. 1976;  94 2072-2077
    PubMedGoogle Scholar
  • 3 Allsop C J, Gallagher P J. Temporal artery biopsy in giant-cell arteritis. A reappraisal.  Amer J Surg Pathol. 1981;  5 317-323
    PubMedGoogle Scholar
  • 4 Andersen S R. Giant-cell arteritis. Horton-Magath-Brown Temporal arteritis, cranial arteritis.  Trans Pac Coast Oto-Ophthalmol Soc Ann Meet. 1969;  50 35-58
    PubMedGoogle Scholar
  • 5 Bacon P A, Doherty S M, Zuckerman A J. Hepatitis-B antibody in polymyalgia rheumatica.  Lancet. 1975;  2 476-478
    PubMedGoogle Scholar
  • 6 Banks P M, Cohen M D, Ginsburg W W. et al . Immunohistologic and cytochemical studies of temporal arteritis.  Arthritis Rheumat. 1983;  26 1201-1207
    PubMedGoogle Scholar
  • 7 Barbazani C, González-Gay M A, Aspe B, Fucinos L, Mantecon-Aparicio J M. Visual recovery after retinal stroke due to giant cell arteritis (Letter).  Clin & Exp Rheumatol. 2000;  18 425-426
    PubMedGoogle Scholar
  • 8 Barricks M E, Traviesa D B, Glaser J S, Levy I S. Ophthalmoplegia in Cranial Arteritis.  Brain. 1977;  100 209-221
    CrossrefPubMedGoogle Scholar
  • 9 Barrier J H, Haldat du Lys F de, Billaudel S. et al . Herpes zoster: serological study and cranial giant cell arteritis.  J Rheumatol. 1986;  13 1190-1191
    PubMedGoogle Scholar
  • 10 Barry M. The use of high-dose pulse methylprednisolone in rheumatoid arthritis. Unproved therapy.  Arch Intern Med. 1985;  145 1483-1484
    CrossrefPubMedGoogle Scholar
  • 11 Bartolome M J, Martínez-Taboda V M, Lopez-Hoyos M, Blanco R, Rodriguez-Valverde V. Familial aggregation of polymyalgia rheumatica and giant cell arteritis: Genetic and T cell repertoire analysis.  Clin Exp Rheumatol. 2001;  19 259-264
    PubMedGoogle Scholar
  • 12 Beck R W, Smith C H. Neuro-Ophthalmology: a problem-oriented approach. Boston, Toronto; Little, Brown & Comp 1988: 53-57
    Google Scholar
  • 13 Becourt-Verlomme C, Barouky R, Alexandre C, Gonthier R, Laurent H, Vital D urand, Rousset H. Symptômes inauguraux de la maladie de Horton sur une série de 260 patients.  Rev Méd Interne. 2001;  22 631-637
    PubMedGoogle Scholar
  • 14 Bell T AG, Gibson R A, Tullo A B. A case of giant-cell arteritis and Horner's Syndrome.  Scott Med J. 1980;  25 302
    PubMedGoogle Scholar
  • 15 Bengtsson B Å, Malmvall B E. Giant cell arteritis.  Acta Med Scand Suppl. 1982;  658 2-102
    PubMedGoogle Scholar
  • 16 Beri M, Klugman M R, Kohler J A, Hayreh S S. Anterior ischemic neuropathy. VII. Incidence of bilaterality and various influencing factors.  Ophthalmology. 1987;  94 1020-1028
    CrossrefPubMedGoogle Scholar
  • 17 Berlit P. Clinical and laboratory findings with giant cell arteritis.  J Neurol Sci. 1992;  111 1-12
    CrossrefPubMedGoogle Scholar
  • 18 Bevan A T, Dunnill M S, Harrison M JG. Clinical and biopsy findings in temporal arteritis.  Ann Rheum Dis. 1968;  27 271-277
    PubMedGoogle Scholar
  • 19 Bisgård C, Sloth H, Keiding N, Juel K. Excess mortality in giant cell arteritis.  J Int Med. 1991;  230 119-123
    PubMedGoogle Scholar
  • 20 Boghen D R, Glaser J S. Ischemic optic neuropathy. The clinical profile and history.  Brain. 1975;  98 689-708
    PubMedGoogle Scholar
  • 21 Bogousslavsky J, Deruaz J P, Regli F. Bilateral obstruction of Internal Carotid Artery from Giant-Cell Arteritis and Massive Infarction Limited to the Vertebrobasilar Area.  Eur Neurol. 1985;  24 57-61
    CrossrefPubMedGoogle Scholar
  • 22 Bohle W, Stettin A, Jipp P. Risikofaktoren für die Entwicklung von Sehstörungen bei Polymyalgia rheumatica mit Riesenzellarteriitis.  Dtsch Med Wschr. 2000;  125 681-685
    PubMedGoogle Scholar
  • 23 Boyev L R, Miller N R, Green W R. Efficacy of unilateral versus bilateral temporal artery biopsies for the diagnosis of giant cell arteritis.  Am J Ophthalmol. 1999;  128 211-215
    CrossrefPubMedGoogle Scholar
  • 24 Brack A, Martinez-Taboada V, Stanson A, Goronzy J J, Weyand C M. Disease pattern in cranial and large-vessel giant cell arteritis.  Arthritis Rheum. 1999;  42 311-317
    CrossrefPubMedGoogle Scholar
  • 25 Bridgeford P H, Lowenstein M, Bocanegra T S. et al . Polymyalgia rheumatica and giant cell arteritis: histocompatibility typing and hepatitis-B infection studies.  Arthritis Rheum. 1980;  23 516-518
    PubMedGoogle Scholar
  • 26 Bronster D J, Rudolph S H, Shanzer S. Pupillary light-near dissociation in cranial arteritis. A case report.  Neuro-Ophthalmology. 1983;  3 65-70
    PubMedGoogle Scholar
  • 27 Bruk M I. A comparison of the articular and vascular manifestations of polymyalgia rheumatica and giant-cell arteritis.  S Afr Med J. 1968;  42 1235-1236
    PubMedGoogle Scholar
  • 28 Cantalejo-Moreira M, Villaverde-García V, Villalba-Yllan A, Martín-Mola E. Multiple cerebral abscesses in a woman with giant cell arteritis (letter).  Clin Exp Rheumatol. 2000;  18 267
    PubMedGoogle Scholar
  • 29 Caselli R J, Hunder G G, Whisnant J P. Neurologic disease in biopsy-proven giant cell (temporal) arteritis.  Neurology. 1988;  38 352-359
    CrossrefPubMedGoogle Scholar
  • 30 Caselli R J. Giant cell (temporal) arteritis: A treatable cause of multi-infarct dementia.  Neurology. 1990;  40 753-755
    PubMedGoogle Scholar
  • 31 Casson R J, Fleming F K, Shaikh A, James B. Bilateral ocular ischemic syndrome secondary to giant cell arteritis.  Arch Ophthalmol. 2001;  119 306-307
    PubMedGoogle Scholar
  • 32 Chan C CK, Paine M, O'Day J. Steroid management in giant cell arteritis.  Br J Ophthalmol. 2001;  85 1061-1064
    CrossrefPubMedGoogle Scholar
  • 33 Chaouat D, Benlahrache C, Yannoutsos H. et al . Pseudo-polyarthrite rhizomélique et maladie de Horton. Recherche de corrélation avec le système H.L.A., le virus HB et la b 2 microglobuline.  Nouv Presse Méd. 1982;  11 101-104
    PubMedGoogle Scholar
  • 34 Chertok P, Leroux J L, Le Marchand M. et al . Orbital pseudo-tumor in temporal arteritis revealed by computerized tomography.  Clin Exp Rheumatol. 1990;  8 587-589
    PubMedGoogle Scholar
  • 35 Chevalet P, Barrier J H, Pottier P, Magadur-Joly G, Pottier M A, Hamidou M, Planchon B, El Kouri D, Connan L, Dupond J L, Wazieres B de, Dien G, Duhamel E, Grosbois B, Jego P, Strat A le, Capdeville J, Letellier P, Agron L. A randomized, multicenter, controlled trial using intravenous pulses of methylprednisolone in the initial treatment of simple forms of giant cell arteritis: a one year follow up study of 164 patients.  J Rheumatol. 2000;  27 1484-1491
    PubMedGoogle Scholar
  • 36 Chmelewski W L, McKnight K M, Agudelo C A, Wise C M. Presenting features and outcomes in patients undergoing temporal artery biopsy. A review of 98 patients.  Arch Intern Med. 1992;  152 1690-1695
    CrossrefPubMedGoogle Scholar
  • 37 Clearkin L, Caballero J. Recovery of visual function in anterior ischemic optic neuropathy due to giant cell arteritis.  Am J Med. 1992;  92 703-704
    CrossrefPubMedGoogle Scholar
  • 38 Crompton M R. The visual changes in temporal (giant-cell) arteritis. Report of a case with autopsy findings.  Brain. 1959;  82 377-390
    PubMedGoogle Scholar
  • 39 Crompton J L, Burrow D J, Iyer P V. Bilateral internuclear ophthalmoplegia - an unusual initial presenting sign of giant cell arteritis.  Austral N Zeal J Ophthalmol. 1989;  17 71-74
    PubMedGoogle Scholar
  • 40 Cullen J F. Occult temporal arteritis. A common cause of blindness in old age.  Br J Ophthalmol. 1967;  51 513-525
    PubMedGoogle Scholar
  • 41 Currie J, Lessell S. Tonic pupil with giant cell arteritis.  Br J Ophthalmol. 1984;  68 135-138
    PubMedGoogle Scholar
  • 42 Daicker B, Keller H H. Riesenzellarteriitis mit endookulärer Ausbreitung und Hypotonia bulbi dolorosa.  Klin Monatsbl Augenheilkd. 1971;  158 358-372
    PubMedGoogle Scholar
  • 43 Daumann C, Putz R, Schmidt D. Der Verlauf der Arteria temporalis superficialis. Anatomische Untersuchungen als Voraussetzung für eine Arterien-Biopsie.  Klin Monatsbl Augenheilkd. 1989;  194 37-41
    Article in Thieme ConnectPubMedGoogle Scholar
  • 44 Diego M, Margo C E. Postural vision loss in giant cell arteritis.  J Neuro-Ophthalmol. 1998;  18 124-126
    PubMedGoogle Scholar
  • 45 Dimant J, Grob D, Brunner N G. Ophthalmoplegia, ptosis, and miosis in temporal arteritis.  Neurology. 1980;  30 1054-1058
    PubMedGoogle Scholar
  • 46 Dorra M, Piette A M, Dechy H, Betourne C l. La maladie de Horton; un diagnostic trop souvent tardif. Plaidoyer pour une biopsie précoce de l'artère temporale.  Sem Hôp Paris. 1984;  60 1137-1138
    PubMedGoogle Scholar
  • 47 Dot C, Hamard P, Metge F, Hamard H. Neuropathie optique ischémique aiguë bilatéralisée en 3 jours dans le cadre d'une maladie de Horton.  J Fr Ophtalmol. 2001;  24 860-864
    PubMedGoogle Scholar
  • 48 Doyle L, McWilliam L, Hasleton P S. Giant cell arteritis with pulmonary involvement.  Br J Dis Chest. 1988;  82 88-92
    CrossrefPubMedGoogle Scholar
  • 49 Duhaut P, Pinède L, Demolombe-Ragué S, Loire R, Seydoux D, Ninet J, Pasquier J. Groupe de Recherche sur l'artérite à cellules géantes . Giant cell arteritis and cardiovascular risk factors. A multicenter, prospective case-control study.  Arthritis Rheum. 1998;  41 1960-1965
    CrossrefPubMedGoogle Scholar
  • 50 Duhaut P, Bosshard S, Calvet A, Pinede L, Demolombe-Ragué S, Dumontet C, Loire R, Seydoux D, Ninet J, Pasquier J, Aymard M. Giant cell arteritis, polymyalgia rheumatica, and viral hypotheses: a multicenter, prospective case-control study.  J Rheumatol. 1999;  26 361-369
    PubMedGoogle Scholar
  • 51 Duhaut P, Pinède L, Bornet H, Demolombe-Ragué S, Dumontet C, Ninet J, Loire R, Pasquier J. GRACG (Groupe de Recherche sur l'artérite à cellules géantes) . Biopsy proven and biopsy negative temporal arteritis: differences in clinical spectrum at the onset of the disease.  Ann Rheum Dis. 1999;  58 335-341
    PubMedGoogle Scholar
  • 52 Eagling E M, Sanders M D, Miller S JH. Ischemic papillopathy, clinical and fluorescein angiographic review of forty cases.  Br J Ophthalmol. 1974;  58 990-1008
    PubMedGoogle Scholar
  • 53 Ellenberger C, Keltner J L, Burde R M. Acute optic neuropathy in older patients.  Arch Neurol. 1973;  28 182-185
    PubMedGoogle Scholar
  • 54 Elling P, Olsson A T, Elling H. Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; association with epidemics of mycoplasma pneumoniae infection.  J Rheumatol. 1996;  23 112-119
    PubMedGoogle Scholar
  • 55 Ellis P P, Gentry J H. Ocular complications of ulcerative colitis.  Am J Ophthalmol. 1964;  58 779-785
    PubMedGoogle Scholar
  • 56 Ellis J D, Munro P, McGettrick P. Blindness with a normal erythrocyte sedimentation rate in giant cell arteritis.  Br J Hosp Med. 1994;  52 358-359
    PubMedGoogle Scholar
  • 57 Eshaghian J. Cranial arteritis: a review of 79 cases.  Stroke. 1980;  11 131
    PubMedGoogle Scholar
  • 58 Espinosa G, Tàssies D, Font J, Muñoz-Rodriguez F J, Cervera R, Ordinas A, Reverter J C, Ingelmo M. Antiphospholipid antibodies and thrombophilic factors in gient cell arteritis.  Semin Arthritis Rheumatol. 2001;  31 13-20
    PubMedGoogle Scholar
  • 59 Evans J M, O'Fallon W M, Hunder G G. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis.  Ann Intern Med. 1995;  122 502-507
    PubMedGoogle Scholar
  • 60 Finelli P F. Alternating amaurosis fugax and temporal arteritis.  Am J Ophthalmol. 1997;  123 850-851
    PubMedGoogle Scholar
  • 61 Fisher C M. Diskussionsbemerkung zu Schlezinger NS, Schatz NJ. Giant cell arteritis (temporal arteritis).  Trans Am Neurol Ass. 1971;  96 12-15
    PubMedGoogle Scholar
  • 62 Fitzgerald D E, Morris L E. Temporal arteritis. A review of some current literature.  J Irish Med Ass. 1967;  60 128-131
    PubMedGoogle Scholar
  • 63 Fledelius H C, Nissen K R. Giant cell arteritis and visual loss. A 3-year retrospective hospital investigation in a Danish county.  Acta Ophthalmol. 1992;  70 801-805
    PubMedGoogle Scholar
  • 64 Font C, Cid M C, Coll-Vinent B, Lopez-Soto A, Grau J M. Clinical features in patients with permanent visual loss due to biopsy-proven giant cell arteritis.  Br J Rheumatol. 1997;  36 251-254
    CrossrefPubMedGoogle Scholar
  • 65 Foroozan R, Danesh-Meyer H V, Savino P J, Gamble G, Mekari-Sabbagh O N, Sergott R C. Thrombocytosis in patients with biopsy-proven giant cell arteritis.  Ophthalmology. 2002;  109 1267-1271
    CrossrefPubMedGoogle Scholar
  • 66 Foroozan R, Buono L M, Savino P J, Sergott R C. Tonic pupils from giant cell arteritis.  Br J Ophthalmol. 2003;  87 510-512
    CrossrefPubMedGoogle Scholar
  • 67 Gabriel S E, O'Fallon W M, Achkar A A, Lie J T, Hunder G G. The use of clinical characteristics to predict the results of temporal artery biopsy among patients with suspected giant cell arteritis.  J Rheumatol. 1995;  22 93-96
    PubMedGoogle Scholar
  • 68 Gabriel S E, Espy M, Erdman D D, Bjornsson J, Smith T F, Hunder G G. The role of parvovirus B19 in the pathogenesis of giant cell arteritis.  Arthritis Rheum. 1999;  42 1255-1258
    CrossrefPubMedGoogle Scholar
  • 69 Ghanchi F D, Weir C, Dudgeon J. Facial swelling in giant cell (temporal) arteritis.  Eye. 1996;  10 747-749
    PubMedGoogle Scholar
  • 70 Ghanchi F D, Dutton G N. Current concepts in giant cell (temporal) arteritis.  Surv Ophthalmol. 1997;  42 99-123
    PubMedGoogle Scholar
  • 71 Gibb W RG, Urry P A, Lees A J. Giant cell arteritis with spinal cord infarction and basilar artery thrombosis.  J Neurol Neurosurg Psych. 1985;  48 945-948
    PubMedGoogle Scholar
  • 72 Gibbs P. Pseudotumours of the orbit.  Br Med J. 1974;  2 445-446
    PubMedGoogle Scholar
  • 73 Gibbs P. Temporal arteritis: onset with pseudotumour orbit or red eye.  Practitioner. 1974;  213 205-211
    PubMedGoogle Scholar
  • 74 Gilbert G J. Eyeball bruits in temporal arteritis.  Dis Nerv Syst. 1970;  31 130-132
    PubMedGoogle Scholar
  • 75 Glutz von Blotzheim S, Borruat F X. Artérite à cellules géantes et vitesse de sédimentation normale: plus qu'un exception!.  Klin Monatsbl Augenheilkd. 1996;  208 397-399
    PubMedGoogle Scholar
  • 76 Glutz von Blotzheim S, Borruat F X. Neuro-ophthalmic complications of biopsy-proven giant cell arteritis.  Europ J Ophthalmol. 1997;  7 375-382
    PubMedGoogle Scholar
  • 77 Gonzalez E B, Varner W T, Lisse J R. et al . Giant-cell arteritis in the southern United States. An 11-year retrospective study from the Texas Gulf Coast.  Arch Intern Med. 1989;  149 1561-1565
    CrossrefPubMedGoogle Scholar
  • 78 González-Gay M A, Blanco R, Rodriguez-Valverde V, Martinez-Taboada V M, Delgado-Rodriguez M, Figueroa M, Uriarte E. Permanent visual loss and cerebrovascular accidents in giant cell arteritis.  Arthritis Rheum. 1998;  41 1497-1504
    CrossrefPubMedGoogle Scholar
  • 79 González-Gay M A, García-Porrúa C, Brañas F. Carotid occlusion mimicking giant cell arteritis (letter).  J Rheumatol. 1998;  25 1247-1248
    PubMedGoogle Scholar
  • 80 González-Gay M A, García-Porrúa C, González-Rosón O. Facial pain and giant cell arteritis (letter).  J Rheumatol. 1998;  25 1242-1243
    PubMedGoogle Scholar
  • 81 González-Gay M A, García-Porrúa C, Brañas F, Alba-Losada J. Giant cell arteritis presenting as occipital neuralgia (letter).  Clin Exp Rheumatol. 2001;  19 479
    PubMedGoogle Scholar
  • 82 González-Gay M A, García-Porrúa C, Llorca J, González-Louzao C, Rodriguez-Ledo P. Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy.  Semin Arthritis Rheum. 2001;  30 249-256
    CrossrefPubMedGoogle Scholar
  • 83 Gouffault J, Chevrel M L, Carrérès D Le, Bourel M. Les aspects cardio-vasculaires de la maladie de Horton.  Cœur Méd Interne. 1969;  8 223-230
    PubMedGoogle Scholar
  • 84 Graham E. Survival in temporal arteritis.  Trans Ophthal Soc U K. 1980;  100 108-110
    PubMedGoogle Scholar
  • 85 Graham E, Holland A, Avery A, Ross Russell R W. Prognosis in giant-cell arteritis.  Br Med J. 1981;  282 269-271
    PubMedGoogle Scholar
  • 86 Gran J T, Myklebust G, Wilsgaard T, Jacobsen B K. Survival in polymyalgia rheumatica and temporal arteritis: a study of 398 cases and matched population controls.  Rheumatology. 2001;  40 1238-1242
    CrossrefPubMedGoogle Scholar
  • 87 Guevara R A, Newman N J, Grossniklaus H. Positive temporal artery biopsy 6 months after prednisolone treatment.  Arch Ophthalmol. 1998;  116 1252-1253
    PubMedGoogle Scholar
  • 88 Hachulla E, Boivin V, Pasturel-Michon U, Fauchais A L, Bouroz-Joly J, Perez-Cousin M, Hatron P Y, Devulder B. Prognostic factors and long-term evolution in a cohort of 133 patients with giant cel arteritis.  Clin Exp Rheumatol. 2001;  19 171-176
    PubMedGoogle Scholar
  • 89 Hall S, Ginsburg W W, Vollertsen R S, Hunder G G. The coexistence of rheumatoid arthritis and giant cell arteritis.  J Rheumatol. 1983;  10 995-997
    PubMedGoogle Scholar
  • 90 Hall S, Hunder G G. Is temporal artery biopsy prudent?.  Mayo Clin Proc. 1984;  59 793-796
    PubMedGoogle Scholar
  • 91 Haslbeck J. Über Augenbefunde bei Arteriitis temporalis.  Bericht Dtsch Ophthalmol Ges Heidelberg. 1953;  58 339-341
    PubMedGoogle Scholar
  • 92 Haugeberg G, Bie R, Nordbo S A. Chlamydia pneumoniae not detected in temporal artery biopsies from patients with temporal arteritis.  Scand J Rheumatol. 2000;  29 127-128
    CrossrefPubMedGoogle Scholar
  • 93 Hayreh S S. Anterior Ischemic Optic Neuropathy. Berlin, Heidelberg, New York; Springer Verlag 1975
    Google Scholar
  • 94 Hayreh S S. Anterior ischaemic optic neuropathy. Differentiation of arteritic from non-arteritic type and management.  Eye. 1990;  4 25-41
    CrossrefPubMedGoogle Scholar
  • 95 Hayreh S S, Podhajsky P A, Raman R, Zimmerman B. Giant cell arteritis: validity and reliability of various diagnostic criteria.  Am J Ophthalmol. 1997;  123 285-296
    CrossrefPubMedGoogle Scholar
  • 96 Hayreh S S, Podhajsky P A, Zimmerman B. Ocular manifestations of giant cell arteritis.  Am J Ophthalmol. 1998;  125 509-520
    CrossrefPubMedGoogle Scholar
  • 97 Hayreh S S, Podhajsky P A, Zimmerman B. Occult giant cell arteritis: ocular manifestations.  Am J Ophthalmol. 1998;  125 521-526
    CrossrefPubMedGoogle Scholar
  • 98 Hayreh S S. Steroid therapy for visual loss in patients with giant-cell arteritis.  Lancet. 2000;  355 1572-1573
    CrossrefPubMedGoogle Scholar
  • 99 Hayreh S S, Zimmerman B. Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy.  Ophthalmology. 2003;  110 1204-1215
    CrossrefPubMedGoogle Scholar
  • 100 Hayreh S S, Zimmerman B. Management of giant cell arteritis. Our 27-year clinical study: new light on old controversies.  Ophthalmologica. 2003;  217 239-259
    CrossrefPubMedGoogle Scholar
  • 101 Hedges T R, Gieger G L, Albert D M. The clinical value of negative temporal artery biopsy specimens.  Arch Ophthalmol. 1983;  101 1251-1254
    PubMedGoogle Scholar
  • 102 Helweg-Larsen J, Tarp B, Obel N, Baslund B. No evidence of parvovirus B19, Chlamydia pneumoniae or herpes virus infection in temporal artery biopsies in patients with giant cell arteritis.  Rheumatology. 2002;  41 445-449
    CrossrefPubMedGoogle Scholar
  • 103 Hoffman G S, Cid M C, Hellmann D B, Guillevin L, Stone J H. et al . A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis.  Arthritis Rheum. 2002;  46 1309-1318
    CrossrefPubMedGoogle Scholar
  • 104 Hollenhorst R W, Brown J R, Wagener H P, Shick R M. Neurologic aspects of temporal arteritis.  Neurology. 1960;  10 490-498
    CrossrefPubMedGoogle Scholar
  • 105 Hunder G G. Giant cell arteritis: a disease of the elderly.  Geriatrics. 1983;  38 55-56, 61 - 62, 64
    PubMedGoogle Scholar
  • 106 Hunder G G. Giant cell arteritis: improving your patient's prognosis.  J Musculoskel Med. 1989;  6 94-105
    PubMedGoogle Scholar
  • 107 Hunder G G, Bloch D A, Michel B A. et al . The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis.  Arthritis Rheum. 1990;  33 1122-1128
    CrossrefPubMedGoogle Scholar
  • 108 Hunder G G. Classification/diagnostic criteria for GCA/PMR.  Clin Exp Rheumatol. 2000;  18 (Suppl 20) S4-S5
    PubMedGoogle Scholar
  • 109 Hunder G G. Clinical features of GCA/PMR.  Clin Exp Rheumatol. 2000;  18 (Suppl 20) S6-S8
    PubMedGoogle Scholar
  • 110 Hutnik C M, Nicolle D A, Munoz D G. Orbital aspergillose. A fatal masquerader.  J Neuro-Ophthalmol. 1997;  17 257-261
    PubMedGoogle Scholar
  • 111 Hutchinson E C, Yates P O. Carotico-vertebral stenosis.  Lancet. 1957;  1 2-8
    PubMedGoogle Scholar
  • 112 Hwang J M, Girkin C A, Perry J D, Lai J C, Miller N R, Hellmann D B. Bilateral ocular ischemic syndrome secondary to giant cell arteritis progressing despite corticosteroid treatment.  Am J Ophthalmol. 1999;  127 102-104
    CrossrefPubMedGoogle Scholar
  • 113 Jacobs R C. Polymyalgia rheumatica in an American Indian.  Arthritis Rheum. 1977;  20 1429
    PubMedGoogle Scholar
  • 114 Jonas J B, Gusek G C, Naumann G OH. Anterior ischemic optic neuropathy: Nonarteritic form in small and giant cell arteritis in normal sized optic discs.  Int Ophthalmol. 1988;  12 119-125
    CrossrefPubMedGoogle Scholar
  • 115 Jonasson F, Cullen J F, Elton R A. Temporal arteritis. A 14-year epidemiological, clinical and prognostic study.  Scott Med J. 1979;  24 111-117
    PubMedGoogle Scholar
  • 116 Jover J A, Hernández-Garcia C, Morado I C, Vargas E, Bañares A, Fernández-Gutiérrez B. Combined treatment of giant-cell arteritis with methotrexate and prednisone. A randomized, double-blind, Placebo-controlled trial.  Ann Intern Med. 2001;  134 106-114
    CrossrefPubMedGoogle Scholar
  • 117 Kariv R, Sidi Y, Gur H. Systemic vasculitis presenting as a tumorlike lesion. Four case reports and analysis of 79 reported cases.  Medicine. 2000;  79 349-359
    PubMedGoogle Scholar
  • 118 Kattah J C, Cupps T, Manz H J, El Khodary A, Caputy A. Occipital artery biopsy: A diagnostic alternative in giant cell arteritis.  Neurology. 1991;  41 949-950
    PubMedGoogle Scholar
  • 119 Kattah J C, Mejico L, Chrousos G A, Zimmerman L E, Manz H J. Pathologic findings in a steroid-responsive optic nerve infarct in giant-cell arteritis.  Neurology. 1999;  53 177-180
    CrossrefPubMedGoogle Scholar
  • 120 Keen H. Cranial arteritis presenting as meningitis.  Br Med J. 1950;  1 993-994
    PubMedGoogle Scholar
  • 121 Kendall D. Some complications of temporal arteritis.  Br Med J. 1953;  2 418-420
    PubMedGoogle Scholar
  • 122 Kimmerling D F, Nordin P F. Cranial arteritis: a case report and discussion.  Ann Intern Med. 1952;  36 1520-1526
    PubMedGoogle Scholar
  • 123 Klein R G, Hunder G G, Stanson A W. et al . Large artery involvement in giant cell (temporal) arteritis.  Ann Intern Med. 1975;  83 806-812
    PubMedGoogle Scholar
  • 124 Klein R G, Campbell R J, Hunder G G, Carney J A. Skip lesions in temporal arteritis.  Mayo Clin Proc. 1976;  51 504-510
    PubMedGoogle Scholar
  • 125 Knecht S, Henningsen H, Rauterberg E W. Immunohistology of temporal arteritis: phenotyping of infiltrating cells and deposits of complement components.  J Neurol. 1991;  238 181-182
    PubMedGoogle Scholar
  • 126 Kollmannsberger A. Über neurologische Komplikationen der Riesenzellarteriitis (sog. Arteriitis temporalis).  Münchn Med Wochenschr. 1969;  111 (1) 1141-1144
    PubMedGoogle Scholar
  • 127 Kupersmith M J, Langer R, Mitnick H, Spiera R, Spiera H, Richmond M, Paget S. Visual performance in giant cell arteritis (temporal arteritis) after 1 year of therapy.  Br J Ophthalmol. 1999;  83 796-801
    CrossrefPubMedGoogle Scholar
  • 128 Beau J Le, Taptas J N, Blatrix C. Un nouveau cas d'artérite temporale thrombosante. Artérite à cellules géantes.  Bull Mém Soc Med Hôp (Paris). 1948;  64 397-399
    PubMedGoogle Scholar
  • 129 Lee K F, Schatz N J. Ischemic chiasmal syndrome.  Acta Radiol Suppl. 1975;  347 131-148
    PubMedGoogle Scholar
  • 130 Lee A G, Eggenberger E R, Kaufman D I, Manrique C. Optic nerve enhancement on magnetic resonance imaging in arteritic ischemic optic neuropathy.  J Neuro-Ophthalmol. 1999;  19 235-237
    PubMedGoogle Scholar
  • 131 Lee A G. Efficacy of unilateral versus bilateral temporal artery biopsies for the diagnosis of giant cell arteritis.  Am J Ophthalmol. 2000;  129 118 (letter)
    PubMedGoogle Scholar
  • 132 Lee A G, Tang R A, Feldon S E, Pless M, Schiffman J S, Rubin R M, Rao N. Orbital presentations of giant cell arteritis.  Graefe's Arch Clin Exp Ophthalmol. 2001;  239 509-513
    PubMedGoogle Scholar
  • 133 Levine S M, Hellmann D B. Giant cell arteritis.  Curr Opin Rheumatol. 2002;  14 3-10
    CrossrefPubMedGoogle Scholar
  • 134 Lie J T, Failoni D D, Davis D C. Temporal arteritis with giant cell aortitis, coronary arteritis, and myocardial infarction.  Arch Pathol Lab Med. 1986;  110 857-860
    PubMedGoogle Scholar
  • 135 Lie J T. The classification and diagnosis of vasculitis in large and medium-sized blood vessels.  Pathol Annu. 1987;  22 125-162
    PubMedGoogle Scholar
  • 136 Lie J T. Occidental (temporal) and oriental (Takayasu) giant cell arteritis.  Cardiovasc Pathol. 1994;  3 227-240
    CrossrefPubMedGoogle Scholar
  • 137 Lie J T. Aortic and extracranial large vessel giant cell arteritis: a review of 72 cases with histopathologic documentation.  Semin Arthritis Rheum. 1995;  24 422-431
    CrossrefPubMedGoogle Scholar
  • 138 Lincoff N S, Erlich P D, Brass L S. Thrombocytosis in temporal arteritis. Rising platelet counts: a red flag for giant cell arteritis.  J Neuro-Ophthalmol. 2000;  20 67-72
    PubMedGoogle Scholar
  • 139 Liozon F, Vidal E, Gaches F. et al . Les décès dans la maladie de Horton. Facteurs de pronostic.  Rev Med Interne. 1992;  13 187-191
    PubMedGoogle Scholar
  • 140 Liozon E, Roblot P, Paire D, Loustaud V, Liozon F, Vidal E, Jauberteau M O. Anticardiolipin antibody levels predict flares and relapses in patients with giant-cell (temporal) arteritis. A longitudinal study of 58 biopsy-proven cases.  Rheumatology. 2000;  39 1089-1094
    CrossrefPubMedGoogle Scholar
  • 141 Liozon E, Herrmann F, Ly K, Robert P Y, Loustaud V, Soria P, Vidal E. Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients.  Am J Med. 2001;  111 211-217
    CrossrefPubMedGoogle Scholar
  • 142 Liozon E, Boutros-Toni F, Ly K, Loustaud-Ratti V, Soria P, Vidal E. Silent, or masked, giant cell arteritis is associated with a strong inflammatory response and a benign short term course.  J Rheumtol. 2003;  30 1272-1276
    PubMedGoogle Scholar
  • 143 Liu G T, Glaser J S, Schatz N J, Smith J L. Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision.  Ophthalmology. 1994;  101 1779-1785
    CrossrefPubMedGoogle Scholar
  • 144 Liu N H, LaBree L D, Feldon S E, Rao N A. The epidemiology of giant cell arteritis. A 12-year retrospective study.  Ophthalmology. 2001;  108 1145-1149
    CrossrefPubMedGoogle Scholar
  • 145 Lotery A, Best J, Houston S. Occult giant cell (temporal) arteritis presenting with bilateral sixth and unilateral fourth nerve palsies.  Eye. 1998;  12 1014-1016
    PubMedGoogle Scholar
  • 146 MacDonald A B. Giant cell arteritis and Borrelia infection.  J Clin Neuro-ophthalmol. 1987;  7 180-181
    PubMedGoogle Scholar
  • 147 Machado E BV, Gabriel S E, Beard C M. et al . A population-based case-control study of temporal arteritis: evidence for an association between temporal arteritis and degenerative vascular disease?.  Int J Epidemiol. 1989;  18 836-841
    CrossrefPubMedGoogle Scholar
  • 148 Mack H G, O'Day J, Currie J N. Delayed choroidal perfusion in giant cell arteritis.  J Clin Neuro-Ophthalmol. 1991;  11 221-227
    PubMedGoogle Scholar
  • 149 Malmvall B E, Bengtsson B Å, Kaijser B. et al . Serum levels of immunoglobulin and complement in giant-cell arteritis.  JAMA. 1976;  236 1876-1878
    CrossrefPubMedGoogle Scholar
  • 150 Malmvall B E, Bengtsson B Å. Giant cell arteritis. Clinical features and involvement of different organs.  Scand J Rheumatol. 1978;  7 154-158
    PubMedGoogle Scholar
  • 151 Mambo N C. Temporal (granulomatous) arteritis: a histopathological study of 32 cases.  Histopathology. 1979;  3 209-221
    CrossrefPubMedGoogle Scholar
  • 152 Manschot W A. A fatal case of temporal arteritis with ocular symptoms.  Ophthalmologica. 1965;  149 121-130
    PubMedGoogle Scholar
  • 153 Martenet A C. Fréquence et importance des symptomes oculaires dans l'artérite à cellule géantes de Horton.  Oto-Neuro-Opht. 1978;  50 7-10
    PubMedGoogle Scholar
  • 154 McHugh N J, James I E, Plant G T. Anticardiolipin and antineutrophil antibodies in giant cell arteritis.  J Rheumatol. 1990;  17 916-922
    PubMedGoogle Scholar
  • 155 McLean C A, Gonzales M F, Dowling J P. Systemic giant cell arteritis and cerebellar infarction.  Stroke. 1993;  24 899-902
    PubMedGoogle Scholar
  • 156 Meadows S P. Temporal or giant cell arteritis - ophthalmic aspects. In: Smith JL (ed) Neuro-Ophthalmology. St. Louis; C. V. Mosby Company 1968 4: 148-157
    Google Scholar
  • 157 Meli B, Landau K, Gloor B P. Die Tücken der Riesenzellarteriitis aus ophthalmologischer Sicht.  Schweiz Med Wochenschr. 1996;  126 1821-1828
    PubMedGoogle Scholar
  • 158 Mulcahy F, Juby L D, Chandler G N. Giant cell arteritis presenting with peripheral neuropathy.  Postgrad Med J. 1984;  60 670-671
    PubMedGoogle Scholar
  • 159 Nadeau S E. Temporal arteritis: a decision-analytic approach to temporal artery biopsy.  Acta Neurol Scand. 1988;  78 90-100
    PubMedGoogle Scholar
  • 160 Nordborg E, Bengtsson B Å. Epidemiology of biopsy-proven giant cell arteritis (GCA).  J Int Med. 1990;  227 233-236
    PubMedGoogle Scholar
  • 161 Nordborg C, Nordborg E, Petursdottir V, LaGuardia J, Mahalingam R, Wellish M, Gilden D H. Search for varicella zoster virus in giant cell arteritis.  Ann Neurol. 1998;  44 413-414
    CrossrefPubMedGoogle Scholar
  • 162 Nordborg E, Nordborg C, Malmvall B E, Andersson R, Nengtsson B Å. Giant cell arteritis.  Rheum Dis Clin North Am. 1995;  21 1013-1026
    PubMedGoogle Scholar
  • 163 Nordborg E, Nordborg C, Petursdottir V. Giant cell arteritis. Epidemiology, etiology and pathogenesis.  APMIS. 2000;  108 713-724
    CrossrefPubMedGoogle Scholar
  • 164 Nordborg C, Johansson H, Petursdottir V, Nordborg E. The epidemiology of biopsy-positive giant cell arteritis: special reference to changes in the age of the population.  Rheumatology. 2003;  42 549-552
    CrossrefPubMedGoogle Scholar
  • 165 Östberg G. Morphological Changes in the large arteries in polymyalgia arteritica.  Acta Med Scand. 1972;  533, suppl 135-164
    PubMedGoogle Scholar
  • 166 Östberg G. On arteritis with special reference to polymyalgia arteritica.  Acta Pathol Microbiol Scand Section A. 1973;  237, Suppl 1-59
    PubMedGoogle Scholar
  • 167 Östberg G. Arterial lesions in polymyalgia arteritica.  Path Microbiol. 1975;  43 182-186 (98 - 102)
    PubMedGoogle Scholar
  • 168 Pache M, Kaiser H J, Haufschild T, Lübeck P, Flammer J. Increased endothelin-1 plasma levels in giant cell arteritis: a report on four patients.  Am J Ophthalmol. 2002;  133 160-162
    CrossrefPubMedGoogle Scholar
  • 169 Palm E. The ocular crisis of the temporal arteritis syndrome (Horton).  Acta Ophthalmol. 1958;  36 208-243
    PubMedGoogle Scholar
  • 170 Papaioannou C C, Trautman J C, Kazmier F J, Hunder G G. Association of giant cell arteritis and pituitary tumor. Report of two cases.  Am J Med Sci. 1979;  277 85-89
    PubMedGoogle Scholar
  • 171 Peter H H. Vaskulitiden. Kapitel 38.  „Klinische Immunologie” der Reihe „Innere Medizin der Gegenwart”. 1991;  9 401-414
    PubMedGoogle Scholar
  • 172 Petursdottir V, Johansson H, Nordborg E, Nordborg C. The epidemiology of biopsy-positive giant cell arteritis: special reference to cyclic fluctuations.  Rheumatology. 1999;  38 1208-1212
    CrossrefPubMedGoogle Scholar
  • 173 Pizzarello L D, MacDonald A B, Semlear R. et al . Temporal arteritis associated with Borrelia infection. A case report.  J Clin Neuro-Ophthalmol. 1989;  9 3-6
    PubMedGoogle Scholar
  • 174 Pless M, Rizzo J F, Lamkin J C, Lessell S. Concordance of bilateral temporal artery biopsy in giant cell arteritis.  J Neuro-Ophthalmol. 2000;  20 216-218
    PubMedGoogle Scholar
  • 175 Radda T M. Arteriitis temporalis Horton. Klinik, Diagnose und Pathomechanismus.  Fortschr Med. 1985;  103 1073-1075
    PubMedGoogle Scholar
  • 176 Rao J K, Allen N B, Pincus T. Limitations of the 1990 American College of Rheumatology classification criteria in the diagnosis of vasculitis.  Ann Int Med. 1998;  129 345-352
    CrossrefPubMedGoogle Scholar
  • 177 Regan M J, Wood B J, Hsieh Y H, Theodore M L, Quinn T C, Hellmann D B, Green W R, Gaydos C A, Stone J H. Temporal arteritis and Chlamydia pneumoniae. Failure to detect the organism by polymerase chain reaction in ninety cases and ninety controls.  Arthritis Rheum. 2002;  46 1056-1060
    CrossrefPubMedGoogle Scholar
  • 178 Regouby Y, Paulus C, Pina C, Lambert de Cursay G. Maladie de Horton avec œdème facial: La „loi des séries”.  Presse Méd. 2001;  30 1463
    PubMedGoogle Scholar
  • 179 Reinhard M, Schmidt D, Schumacher M, Hetzel A. Involvement of the vertebral arteries in giant cell arteritis mimicking vertebral dissection. J Neurol in press
    Google Scholar
  • 180 Reinhold-Keller E, Zeidler A, Gutfleisch J, Peter H H, Raspe H H, Gross W L. Giant cell arteritis is more prevalent in urban than in rural populations: results of an epidemiological study of primary systemic vasculitides in Germany.  Rheumatology. 2000;  39 1396-1402
    CrossrefPubMedGoogle Scholar
  • 181 Reuther R, Betz H. Arteriitis temporalis mit ischämischer Kopfhaut- und Zungennekrose.  Nervenarzt. 1972;  43 257-262
    PubMedGoogle Scholar
  • 182 Rimenti G, Blasi F, Cosentini R, Moling O, Pristerá R, Tarsia P, Vedovelli C, Mian P. Temporal arteritis associated with Chlamydia pneumoniae DNA detected in an artery specimen.  J Rheumatol. 2000;  27 2718-2720
    PubMedGoogle Scholar
  • 183 Ross Russell R W. Giant-cell arteritis. A review of 35 cases.  Quart J Med. 1959;  28 471-489
    PubMedGoogle Scholar
  • 184 Rüegg S, Engelter S, Jeanneret C, Hetzel A, Probst A, Steck A J, Lyrer P. Bilateral vertebral artery occlusion resulting from giant cell arteritis. Report of 3 cases and review of the literature.  Medicine. 2003;  82 1-12
    CrossrefPubMedGoogle Scholar
  • 185 Rush J A, Kramer L D. Biopsy-negative cranial arteritis with complete oculomotor nerve palsy.  Ann Ophthalmol. 1979;  11 209-213
    PubMedGoogle Scholar
  • 186 Sachers F, Frey L D, Forrer A. Indikationen zur Biopsie der Arteria temporalis.  Klin Monatsbl Augenheilkd. 1993;  202 373-375
    PubMedGoogle Scholar
  • 187 Sadun F, Pece A, Brancato R. Fluorescein and indocyanine green angiography in arteritic anterior ischaemic optic neuropathy.  Br J Ophthalmol. 1998;  82 1344-1345
    PubMedGoogle Scholar
  • 188 Säve-Söderbergh J, Malmvall B E, Andersson R, Bengtsson B Å. Giant cell arteritis as a cause of death. Report of nine cases.  JAMA. 1986;  255 493-496
    CrossrefPubMedGoogle Scholar
  • 189 Salvarani C, Macchioni P, Boiardi L. et al . Soluble interleukin 2 receptors in polymyalgia rheumatica/giant cell arteritis. Clinical and laboratory correlations.  J Rheumatol. 1992;  19 1100-1106
    PubMedGoogle Scholar
  • 190 Salvarani C, Hunder G G. Giant cell arteritis with low erythrocyte sedimentation rate: Frequency of occurrence in a population-based study.  Arthritis Care Research. 2001;  45 140-145
    CrossrefPubMedGoogle Scholar
  • 191 Sanders M D. Ischaemic papillopathy.  Trans Ophthalmol Soc UK. 1971;  91 369-386
    PubMedGoogle Scholar
  • 192 Sawle G V, James C B, Ross Russell R W. The natural history of non-arteritic anterior ischaemic optic neuropathy.  J Neurol Neurosurg Psychiatry. 1990;  53 830-833
    PubMedGoogle Scholar
  • 193 Schlezinger N S, Schatz N. Giant cell arteritis (temporal arteritis).  Trans Amer Neurol Assoc. 1971;  96 12-15
    PubMedGoogle Scholar
  • 194 Schmidt D, Richter T, Reutern G M von, Engelhardt R. Akute Durchblutungsstörungen des Auges. Klinische Befunde und Ergebnisse der Doppler-Sonographie der A. carotis interna.  Fortschr Ophthalmol. 1991;  88 84-98
    PubMedGoogle Scholar
  • 195 Schmidt D. Bulbusmassage zur Behandlung eines Zentralarterienverschlusses infolge Arteriitis temporalis (Horton).  Z prakt Augenheilk. 1992;  13 21-27
    PubMedGoogle Scholar
  • 196 Schmidt D. Letter to the Editor (Answer to the publication by Tomsak RL. Superficial temporal artery biopsy. A simplified technique. J Clin Neuro-ophthalmol 1991; 11: 202 - 204).  J Clin Neuro-ophthalmol. 1992;  12 135-136
    PubMedGoogle Scholar
  • 197 Schmidt D, Löffler K U. Temporal arteritis. Comparison of histological and clinical findings.  Acta Ophthalmologica. 1994;  72 319-325
    PubMedGoogle Scholar
  • 198 Schmidt D. Die Arteriitis temporalis Horton. Diagnose, Differenzialdiagnose, Therapie. St. Gallen, Schweiz; Elephas Buchverlag 1995
    Google Scholar
  • 199 Schmidt D. Arteriitis temporalis Horton. Teil 1: Symptome, klinische Diagnostik.  Z prakt Augenheilk. 1996;  17 25-32
    PubMedGoogle Scholar
  • 200 Schmidt D. Arteriitis temporalis Horton. Teil 2: Labordiagnostik, Therapie.  Z prakt Augenheilk. 1996;  17 101-106
    PubMedGoogle Scholar
  • 201 Schmidt D, Richter B. Hals-Nasen-Ohren-Befunde bei Arteriitis temporalis Horton. Literaturübersicht und Falldarstellung.  HNO. 1999;  47 176-182
    CrossrefPubMedGoogle Scholar
  • 202 Schmidt D, Zehender M. Arterienverschluss des Auges bei infektiöser Endokarditis.  Ophthalmologe. 1999;  96 264-266
    CrossrefPubMedGoogle Scholar
  • 203 Schmidt D, Vaith P, Hetzel A. Prevention of serious ophthalmic and cerebral complications in temporal arteritis? 1st International Conference on Polymyalgia rheumatica and Giant Cell Arteritis. Prato/Italy, 25 - 26 May, 1999.  Clin Exp Rheumatol. 2000;  18 (Suppl 20) S61-S63
    PubMedGoogle Scholar
  • 204 Schmidt D, Schulte-Mönting J. Letter to the Editor. Giant cell arteritis is more prevalent in urban than in rural populations. Rheumatology 2001; 40: 1193. Comment on the article by Reinhold-Keller et al.  Rheumatology. 2000;  39 1396-1402
    CrossrefPubMedGoogle Scholar
  • 205 Schmidt D, Adelmann G. The course of the occipital artery - an anatomical investigation for biopsy in suspected vasculitis.  Europ J Med Res. 2001;  6 235-241
    PubMedGoogle Scholar
  • 206 Schmidt D. Fehlbeurteilung eines Arterienastverschlusses. Tübingen; 85. Tagung der Württembergischen Augenärztlichen Vereinigung 24./25.3.2001 (gedruckt im Internet der Univ.-Augenklinik Tübingen)
    Google Scholar
  • 207 Schmidt D, Lagrèze W, Vaith P. Ophthalmoskopischer Befund bei 3 Patienten mit Panarteriitis nodosa und Literaturübersicht.  Klin Monatsbl Augenheilkd. 2001;  218 44-50
    Article in Thieme ConnectPubMedGoogle Scholar
  • 208 Schmidt D, Hetzel A, Reinhard M, Auw-Haedrich C. Comparison between color duplex ultrasonography and histology of the temporal artery in cranial arteritis (giant cell arteritis).  Eur J Med Res. 2003;  8 1-7
    PubMedGoogle Scholar
  • 209 Schmidt W A, Kraft H E, Vorpahl K, Völker L, Gromnica-Ihle E J. Color duplex ultrasonography in the diagnosis of temporal arteritis.  N Engl J Med. 1997;  337 1336-1342
    CrossrefPubMedGoogle Scholar
  • 210 Schmidt W A, Gromnica-Ihle E. Incidence of temporal arteritis in patients with polymyalgia rheumatica: a prospective study using colour Doppler ultrasonography of the temporal arteries.  Rheumatology. 2002;  41 46-52
    CrossrefPubMedGoogle Scholar
  • 211 Scott G I. Optic disc oedema.  Trans Ophthal Soc UK. 1968;  87 733-753
    PubMedGoogle Scholar
  • 212 Scott K R, Tse D T, Kronish J W. Temporal artery biopsy technique: a clinico-anatomical approach.  Ophth Surg. 1991;  22 519-525
    PubMedGoogle Scholar
  • 213 Seitz R. Die Riesenzellarteriitis als Ursache akuter Erblindung.  Klin Monatsbl Augenheilkd. 1958;  132 383-403
    PubMedGoogle Scholar
  • 214 Shah P, Murray P I, Harry J. An unusual case of giant cell arteritis.  Am J Ophthalmol. 1993;  115 393-394
    PubMedGoogle Scholar
  • 215 Shults W T. Ischemic optic neuropathy. Still the ophthalmologist's dilemma.  Ophthalmology. 1984;  91 1338-1341
    PubMedGoogle Scholar
  • 216 Siatkowski R M, Gass J D, Glaser J S, Smith J L, Schatz N J, Schiffman J. Fluorescein angiography in the diagnosis of giant cell arteritis.  Am J Ophthalmol. 1993;  115 57-63
    PubMedGoogle Scholar
  • 217 Slavin M L. Brow droop after superficial temporal artery biopsy.  Arch Ophthalmol. 1986;  104 1127
    PubMedGoogle Scholar
  • 218 Smith C A, Fidler W J, Pinals R S. The epidemiology of giant cell arteritis. Report of a ten-year study in Shelby County, Tennessee.  Arthritis Rheum. 1983;  26 1214-1219
    CrossrefPubMedGoogle Scholar
  • 219 Soelberg-Sørensen P, Lorenzen I. Giant-cell arteritis, temporal arteritis and polymyalgia rheumatica. A retrospective study of 63 patients.  Acta Med Scand. 1977;  201 207-213
    PubMedGoogle Scholar
  • 220 Sonnenblick M, Nesher G, Rosin A. Nonclassical organ involvement in temporal arteritis.  Sem Arthritis Rheum. 1989;  19 183-190
    PubMedGoogle Scholar
  • 221 Spetzler R F, Hadley M N. et al . Vertebrobasilar insufficiency.  J Neurosurg. 1987;  66 648-661
    PubMedGoogle Scholar
  • 222 Spiera R F, Mitnick H J, Kupersmith M, Richmond M, Spiera H, Peterson M GE, Paget S A. A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis.  Clin Exp Rheumatol. 2001;  19 495-501
    PubMedGoogle Scholar
  • 223 Strempel I, Fritzsche R. Arteriitis temporalis - eine retrospektive Studie.  Fortschr Ophthalmol. 1987;  84 364-366
    PubMedGoogle Scholar
  • 224 Thomson G TD, Johnston J L, Sharpe J A, Inman R D. Internuclear ophthalmoplegia in giant cell arteritis.  J Rheumatol. 1989;  16 693-695
    PubMedGoogle Scholar
  • 225 Thystrup J, Knudsen G M, Mogensen A M, Fledelius H C. Atypical visual loss in giant cell arteritis.  Acta Ophthalmol. 1994;  72 759-764
    PubMedGoogle Scholar
  • 226 Trend P, Graham E. Internuclear ophthalmoplegia in giant-cell arteritis.  J Neurol Neurosurg Psychiatry. 1990;  53 532-533
    PubMedGoogle Scholar
  • 227 Turlakow A, Yeung H WD, Pui J, Macapinlac H, Liebovitz E, Rusch V, Goy A, Larson S M. Fludeoxyglucose positron emission tomography in the diagnosis of giant cell arteritis.  Arch Intern Med. 2001;  161 1003-1007
    CrossrefPubMedGoogle Scholar
  • 228 Uddhammar A, Eriksson A L, Nyström L, Stenling R, Rantapää-Dahlqvist S. Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden.  J Rheumatol. 2002;  29 737-742
    PubMedGoogle Scholar
  • 229 Vaith P. et al . Polymyalgia rheumatica nach Borrelieninfektion.  Immun Infekt. 1988;  16 71-73
    PubMedGoogle Scholar
  • 230 Valmaggia C, Speiser P, Bischoff P, Niederberger H. Indocyanine green versus fluorescein angiography in the differential diagnosis of arteritic and nonarteritic anterior ischemic optic neuropathy.  Retina. 1999;  19 131-134
    CrossrefPubMedGoogle Scholar
  • 231 Vollrath-Junger C, Gloor B. Warum eine Doppler-Sonographie vor jeder Biopsie der A. temporalis?.  Klin Monatsbl Augenheilkd. 1989;  195 169-171
    Article in Thieme ConnectPubMedGoogle Scholar
  • 232 Wagener H P, Hollenhorst R W. The ocular lesions of temporal arteritis. Trans.  Am Ophthalm Soc. 1957;  55 249-273
    PubMedGoogle Scholar
  • 233 Wagner A D, Gérard H C, Fresemann T, Schmidt W A, Gromnica-Ihle E, Hudson A P, Zeidler H. Detection of Chlamydia pneumoniae in giant cell vasculitis and correlation with the topographic arrangement of tissue-infiltrating dendritic cells.  Arthritis Rheum. 2000;  43 1543-1551
    CrossrefPubMedGoogle Scholar
  • 234 Walsh F B, Hoyt W F. Giant Cell Arteritis: Arteritis of the Aged (Temporal Arteritis, Cranial Arteritis, Polymyalgia Rheumatica); 1878 - 1886. In: Clinical Neuro-Ophthalmology. Baltimore; Williams & Wilkins 1969
    Google Scholar
  • 235 Watts M T, Greaves M, Rennie I G, Clearkin L G. Antiphospholipid antibodies in the aetiology of ischaemic optic neuropathy.  Eye. 1991;  5 75-79
    PubMedGoogle Scholar
  • 236 Weems J J. Diagnosis of giant cell arteritis by occipital artery biopsy.  Am J Med. 1992;  93 231-232
    CrossrefPubMedGoogle Scholar
  • 237 Wells K K, Folberg R, Goeken J A, Kemp J D. Temporal artery biopsies. Correlation of light microscopy and immunofluorescence microscopy.  Ophthalmology. 1989;  96 1058-1064
    PubMedGoogle Scholar
  • 238 Wenkel H. Bilaterale Amaurose bei 11 Patienten mit histologisch gesicherter Riesenzellarteriitis.  Klin Monatsbl Augenheilkd. 2001;  218 658-661
    Article in Thieme ConnectPubMedGoogle Scholar
  • 239 Weyand C M, Hicok K C, Hunder G G, Goronzy J J. The HLA-DRB 1 locus as a genetic component in giant cell arteritis. Mapping of a disease-linked sequence motif to the antigen binding site of the HLA-DR molecule.  J Clin Invest. 1992;  90 2355-2361
    PubMedGoogle Scholar
  • 240 Weyand C M, Hunder N NH, Hicok K C. et al . HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis.  Arthritis Rheum. 1994;  37 514-520
    CrossrefPubMedGoogle Scholar
  • 241 Weyand C M, Goronzy J J. Arterial wall injury in giant cell arteritis.  Arthritis Rheum. 1999;  42 844-853
    CrossrefPubMedGoogle Scholar
  • 242 Weyand C M. The pathogenesis of giant cell arteritis.  J Rheumatol. 2000;  27 517-522
    PubMedGoogle Scholar
  • 243 Weyand C M, Fulbright J W, Hunder G G, Evans J M, Goronzy J J. Treatment of giant cell arteritis. Interleukin-6 as a biologic marker of disease activity.  Arthritis Rheum. 2000;  43 1041-1048
    CrossrefPubMedGoogle Scholar
  • 244 Weyand C M, Kaiser M, Yang H, Younge B, Goronzy J J. Therapeutic effects of acetylsalicylic acid in giant cell arteritis.  Arthritis Rheum. 2002;  46 457-466
    CrossrefPubMedGoogle Scholar
  • 245 Wiggins R E. Invasive aspergillose. A complication of treatment of temporal arteritis.  J Neuro-Ophthalmol. 1995;  15 36-38
    PubMedGoogle Scholar
  • 246 Wilcox J N, Scott N A. Potential role of the adventitia in arteritis and atherosclerosis.  Int J Cardiol. 1996;  54, Suppl 21-35
    CrossrefPubMedGoogle Scholar
  • 247 Wilhelm H. Pupillotonie durch Ischämie.  Fortschr Ophthalmol. 1989;  86 380-382
    PubMedGoogle Scholar
  • 248 Wilkinson I MS. The vertebral artery. Extracranial and intracranial structure.  Arch Neurol. 1972;  27 392-396
    PubMedGoogle Scholar
  • 249 Wilkinson I MS, Russell R WR. Arteries of the head and neck in giant cell arteritis. A pathological study to show the pattern of arterial involvement.  Arch Neurol. 1972;  27 378-391
    CrossrefPubMedGoogle Scholar
  • 250 Wilske K R, Healey L A. Clinical manifestations of biopsy-proven giant cell arteritis.  Arthritis Rheum. 1971;  14 424
    PubMedGoogle Scholar
  • 251 Wollensak J. Arteriitis temporalis. In: Bücherei des Augenarztes. 1981; Heft 87. Stuttgart; F. Enke-Verlag
    Google Scholar
  • 252 Wyble M, Schimek R A. The simultaneous occurrence of two collagen diseases in the same patient.  Trans Am Acad Ophthalmol Otolaryngol. 1962;  66 632-691
    PubMedGoogle Scholar
  • 253 Wykes W N, Cullen J F. Headache and temporal arteritis.  Scott Med J. 1985;  30 42
    PubMedGoogle Scholar
  • 254 Youinou P Y, Pennec Y, Tande D, Menn G le. Immune complexes and autoantibodies in patients with giant cell arteritis and their relationship with autologous rosette-forming cells.  Clin Exp Rheumatol. 1985;  3 17-21
    PubMedGoogle Scholar

Prof. Dr. Dieter Schmidt

Universitäts-Augenklinik

Killianstraße 5

79106 Freiburg

Phone: 0761/270-4001

Fax: 0761/270-4075

Email: schmidtd@aug.ukl.uni-freiburg.de

      >